Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.

MLA

Mestdagh, M., et al. “Relationship between Pyrazinamide Resistance, Loss of Pyrazinamidase Activity, and Mutations in the PncA Locus in Multidrug-Resistant Clinical Isolates of Mycobacterium Tuberculosis.” Antimicrobial Agents and Chemotherapy, vol. 43, no. 9, Sept. 1999, pp. 2317–19. EBSCOhost, https://doi.org/10.1128/AAC.43.9.2317.

APA

Mestdagh, M., Fonteyne, P. A., Realini, L., Rossau, R., Jannes, G., Mijs, W., De Smet, K. A., Portaels, F., & Van den Eeckhout, E. (1999). Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 43(9), 2317–2319. https://doi.org/10.1128/AAC.43.9.2317

Chicago

Mestdagh, M, P A Fonteyne, L Realini, R Rossau, G Jannes, W Mijs, K A De Smet, F Portaels, and E Van den Eeckhout. 1999. “Relationship between Pyrazinamide Resistance, Loss of Pyrazinamidase Activity, and Mutations in the PncA Locus in Multidrug-Resistant Clinical Isolates of Mycobacterium Tuberculosis.” Antimicrobial Agents and Chemotherapy 43 (9): 2317–19. doi:10.1128/AAC.43.9.2317.